A detailed history of Rafferty Asset Management, LLC transactions in Xencor Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 64,273 shares of XNCR stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,273
Previous 95,515 32.71%
Holding current value
$1.55 Million
Previous $1.81 Million 28.54%
% of portfolio
0.0%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.7 - $21.65 $490,499 - $676,389
-31,242 Reduced 32.71%
64,273 $1.29 Million
Q2 2024

Aug 13, 2024

SELL
$18.21 - $24.5 $2.44 Million - $3.28 Million
-133,856 Reduced 58.36%
95,515 $1.81 Million
Q1 2024

May 13, 2024

BUY
$18.65 - $26.52 $2.04 Million - $2.91 Million
109,553 Added 91.43%
229,371 $5.08 Million
Q4 2023

Feb 13, 2024

BUY
$16.53 - $21.42 $150,935 - $195,586
9,131 Added 8.25%
119,818 $2.54 Million
Q3 2023

Nov 13, 2023

SELL
$20.08 - $25.39 $165,298 - $209,010
-8,232 Reduced 6.92%
110,687 $2.23 Million
Q2 2023

Aug 11, 2023

SELL
$24.77 - $29.9 $199,869 - $241,263
-8,069 Reduced 6.35%
118,919 $2.97 Million
Q1 2023

May 11, 2023

BUY
$25.95 - $36.95 $270,580 - $385,277
10,427 Added 8.95%
126,988 $3.54 Million
Q4 2022

Feb 13, 2023

BUY
$24.79 - $30.86 $55,009 - $68,478
2,219 Added 1.94%
116,561 $3.04 Million
Q3 2022

Nov 14, 2022

BUY
$24.62 - $32.44 $1.12 Million - $1.47 Million
45,323 Added 65.67%
114,342 $2.97 Million
Q2 2022

Aug 12, 2022

SELL
$19.74 - $29.01 $487,183 - $715,966
-24,680 Reduced 26.34%
69,019 $1.89 Million
Q1 2022

May 13, 2022

BUY
$26.68 - $41.63 $771,185 - $1.2 Million
28,905 Added 44.61%
93,699 $2.5 Million
Q4 2021

Feb 10, 2022

BUY
$33.67 - $43.44 $655,756 - $846,037
19,476 Added 42.98%
64,794 $2.6 Million
Q3 2021

Nov 10, 2021

SELL
$30.65 - $35.68 $85,513 - $99,547
-2,790 Reduced 5.8%
45,318 $1.48 Million
Q2 2021

Aug 10, 2021

SELL
$34.33 - $44.68 $419,443 - $545,900
-12,218 Reduced 20.25%
48,108 $1.66 Million
Q1 2021

May 10, 2021

BUY
$40.81 - $53.88 $1.98 Million - $2.61 Million
48,469 Added 408.78%
60,326 $2.6 Million
Q4 2020

Feb 10, 2021

SELL
$36.63 - $47.63 $555,347 - $722,118
-15,161 Reduced 56.11%
11,857 $517,000
Q3 2020

Nov 13, 2020

BUY
$30.09 - $43.02 $227,239 - $324,887
7,552 Added 38.8%
27,018 $1.05 Million
Q2 2020

Aug 07, 2020

BUY
$27.76 - $33.42 $540,376 - $650,553
19,466 New
19,466 $631,000
Q1 2020

May 15, 2020

SELL
$20.69 - $37.79 $613,417 - $1.12 Million
-29,648 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$32.75 - $41.43 $1.56 Million - $1.98 Million
-47,782 Reduced 61.71%
29,648 $1.02 Million
Q3 2019

Nov 14, 2019

BUY
$33.73 - $46.27 $1.58 Million - $2.17 Million
46,989 Added 154.36%
77,430 $2.61 Million
Q2 2019

Aug 09, 2019

SELL
$29.6 - $40.93 $98,627 - $136,378
-3,332 Reduced 9.87%
30,441 $1.25 Million
Q1 2019

May 15, 2019

BUY
$27.85 - $38.09 $940,578 - $1.29 Million
33,773 New
33,773 $1.05 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.44B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.